Navigation Links
Brain Injury Association of Michigan Outlines the Current State of Brain Injury
Date:6/24/2008

h Research and Services Administration-Maternal and Child Health Bureau. The MDCH's TBI Services and Prevention Council, chaired by Michael Dabbs, president of the BIAMI, offers guidance and expertise to the Project, providing recommendations for the use of funding. With the TBI Council's support and guidance, the TBI Grant Project is making great strides in Michigan:

-- The data collection efforts will assist the legislature and state agencies to determine how to more appropriately and cost effectively address the needs of Michigan residents who sustain a TBI.

-- Outreach and support to veterans is being increased.

-- Support and education are being provided to schools and community groups regarding youth sports concussion.

-- The Project actively supports legislation requiring children between four and eight years of age to be restrained in a booster seat while riding in a motor vehicle.

The state of brain injury in Michigan is one of steady progress in the face of incredible odds. The BIAMI and MDCH's TBI Council are fighting diligently to provide the best rehabilitation environment possible to the rising population of TBI survivors, both military and civilian, and to maintain Michigan's superior continuum of care against what can only be described as relentless opposition.

"As that continuum of care is being threatened," said Michael Dabbs, "our level of dedication to the brain injury community we serve here in Michigan has never been greater."

About the Brain Injury Association of Michigan

The Brain Injury Association of Michigan (BIAMI) was founded in 1981 by family members, persons with brain injury and persons in the brain injury profession. At the time, brain injuries were largely misunderstood and services for those affected were hard to find. In the years since its inception, much progress has been made in treating brain injuries, and the BIAMI has expanded its focus to include prevention programs. T
'/>"/>

SOURCE Brain Injury Association of Michigan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Study uncovers how Ritalin works in brain to boost cognition, focus attention
2. Researchers develop neural implant that learns with the brain
3. Brain Scans Detect Alzheimers Disease Quickly
4. Senior Falls Can Lead to Brain Injury
5. Traumatic Brain Injuries Can Result From Senior Falls
6. Study shows that chronic grief activates pleasure areas of the brain
7. Brains Olfactory Bulb Grows With Sense of Smell
8. Star-Shaped Brain Cells Make Scans Possible
9. Neuroscientists show insulin receptor signaling regulates structure of brain circuits
10. Brain Activity May Predict Schizophrenia Behavior
11. Wavelets crunch through doctors day long struggle to diagnose brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) February 28, 2015 The ... is offering a new special. Throughout all of ... , This service can help ... problems and pain. Patients may notice certain symptoms that ... relining. These symptoms include: , 1.    Pain, clicking, and ...
(Date:2/28/2015)... Vancouver, BC (PRWEB) February 28, 2015 ... has recently announced that they now provide business consulting ... services, such as corporate tax planning and succession planning. ... be entrusted to experienced professionals. On top of this, ... difficult to handle corporate accounting. As a result, Mew ...
(Date:2/28/2015)... 2015 Indosoft Inc , developers ... Asterisk, are pleased to announce the development of Q-Suite ... 5.8 versions of Q-Suite, this new version will include ... of new features to the leading edge call center ... 5.9 will add features to enhance security and protection. ...
(Date:2/28/2015)... For those people who are unable to attend ... Research Foundation (Meso Foundation) will broadcast its Symposium ... 9:30 AM. , The live broadcast is free of ... accessed through any browser on a computer or smartphone/device ... a unique event that covers important treatment information and ...
(Date:2/28/2015)... 2015 Pioneer Millworks reclaimed USA wood ... & Construction Materials Show, an annual, premier sustainable building ... suppliers and top manufacturers of the latest building products, ... sourced and manufactured by Pioneer Millworks from their ... Japan at restaurants, hotels, retailers, and corporate offices. ...
Breaking Medicine News(10 mins):Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... - When administered before chemoradiation, the common anti-cancer drug ... of colostomies needed when compared to the standard treatment ... study published in the April 23 issue of the ... the largest cooperative phase III randomized controlled trial of ...
... Experimental use of cisplatin no better than standard treatment, ... -- Compared to the standard treatment regimen for anal ... before other treatments didn,t improve disease-free survival and resulted ... U.S. study. , Currently, the preferred primary therapy for ...
... SAN JOSE, Calif., April 22 VNUS(R) Medical,Technologies, ... of medical devices,for the minimally invasive treatment of ... teleconference and webcast,held yesterday at 2:00 p.m. PT/5:00 ... the Question-and-Answer period did not,take place as planned., ...
... (NYSE: PER ) and Surgical Care Affiliates ... will implement advanced technology,solutions to serve as a ... will help SCA improve support for its more ... and surgical,hospitals across the country. Perot Systems, services ...
... 22 Honda Motor Co., Ltd. will showcase an,experimental ... walking,for the elderly and other people with weakened leg ... & Rehabilitation for,the Elderly & the Disabled (BARRIER FREE ... 25 through Sunday, April 27, 2008., (Photo: ...
... April 22, 2008 Help is on the way for ... suffer from chronic pain in their backs and legs, thanks ... specialists. , Called a hybrid technique, the procedure ... cord) stimulator with a newer technology known as peripheral nerve ...
Cached Medicine News:Health News:Study finds cisplatin less effective than standard treatment for patients with anal cancer 2Health News:New Anal Cancer Therapy Fails to Improve Outcomes 2Health News:Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions 2Health News:Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions 3Health News:Honda to Showcase Experimental Walking Assist Device 2Health News:Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs 2Health News:Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs 3
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. ... from a pre-clinical study published in the ... ( www.pnas.org/cgi/doi/10.1073/pnas.1500712112 ) that showed when ibrutinib (IMBRUVICA ... (a checkpoint inhibitor), suppression of tumor growth was ... when treating certain hematologic cancers and solid tumors ...
(Date:2/27/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced ... loss (NOL) guidance and its cash guidance ending the ... financial results were due in large part to the ... from its partners.  Isis, pro forma NOL of $16.3 ... its 2013 NOL of $40.2 million. On a GAAP ...
(Date:2/27/2015)... 2015   Synageva BioPharma Corp. (Synageva) ... developing therapeutic products for rare diseases, joins the ... Organisation for Rare Diseases™ (EURORDIS™), The Global Genes ... Rare Disease Day. On the last ... and other participants conduct special events to raise ...
Breaking Medicine Technology:In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... 2011 In the press release, "Lilly Presents Data ... 2011, by Eli Lilly and Company (NYSE: LLY ... overall responses were as follows:  one partial response in the ... disease of 41 percent (n=9) in leiomyosarcoma; 35 percent (n=6) ...
... Holdings, Inc., (NYSE: HRC ) invites you to ... Annual Health Care Conference in Los Angeles on June 8, ... to listen to the live discussion via the internet link ... http://cc.talkpoint.com/gold006/060711a_lr/?entity=37_TJC531W .  A recorded replay of the discussion will be ...
Cached Medicine Technology:Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 2Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 3Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 4Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 5Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 6
... CycloPhotocoagulation (ECP) is a surgical approach to ... visualized laser application. The ciliary body (which ... surgeon, from the anterior or posterior segment, ... target tissues are easily and accurately identified ...
... CycloPhotocoagulation (ECP) is a surgical approach to ... visualized laser application. The ciliary body (which ... surgeon, from the anterior or posterior segment, ... target tissues are easily and accurately identified ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
Medicine Products: